Vor Bio
The Director, Statistical Programming at Vor leads statistical programming initiatives across clinical studies, collaborates with cross-functional teams, and ensures compliance with global regulatory standards. The role involves strategic leadership, technical expertise, and quality control of SAS programs for clinical data analysis and submission.
Vor Bio is a clinical-stage cell and genome engineering company developing novel hematopoietic stem cell-based therapies for cancer. The company is focused on transforming the treatment of hematological malignancies through engineered stem cell transplantation and targeted therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Vor Bio.
11% above the average for this role
Vor, with new CEO, changes course to target autoimmune disease
Jun 26, 2025
Director Statistical Programming United Kingdom
alnylam
Statistical Programming Contractor
CRISPR Therapeutics
Associate Director, Statistical Programming
Corcept Therapeutics
Associate Director - Statistical Programming
AstraZeneca
Director, Statistical Programming
Seaport Therapeutics
Associate Director, Statistical Programming
Corcept Therapeutics